Equities

Hamilton Thorne Ltd

Hamilton Thorne Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CAD)2.24
  • Today's Change0.01 / 0.45%
  • Shares traded13.91k
  • 1 Year change+63.50%
  • Beta0.4143
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.

  • Revenue in CAD (TTM)101.58m
  • Net income in CAD-2.37m
  • Incorporated2007
  • Employees--
  • Location
    Hamilton Thorne Ltd100 Cummings Ctr Ste 465eBEVERLY 01915-6143United StatesUSA
  • Phone+1 (978) 921-2050
  • Fax+1 (978) 921-0250
  • Websitehttps://www.hamiltonthorne.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SANUWAVE Health Inc34.85m-4.80m272.83m31.00------7.83-3.55-3.558.17-12.561.243.908.34803,064.50-17.07-136.54----71.5769.13-13.79-189.600.09990.1199----21.8461.61-150.72------
Profound Medical Corp12.57m-43.93m277.20m131.00--6.38--22.05-1.87-1.870.53151.760.19390.49241.3595,984.78-67.74-38.41-77.69-41.9562.0250.32-349.41-387.155.16--0.167--7.7529.090.3488------
Sight Sciences Inc111.34m-70.48m280.25m214.00--2.11--2.52-1.01-1.011.601.880.49681.555.33371,696.30-31.45-38.78-34.47-42.2085.1180.74-63.30-105.149.74-222.930.2645--13.6360.8435.59--6.77--
Orchestra Biomed Holdings Inc2.91m-77.79m321.36m56.00--4.93--110.44-1.57-1.570.05861.230.0211.3416.5737,125.00-56.06---64.66--92.02---2,673.26--4.58--0.00---21.88---37.91------
Jin Medical International Ltd28.17m4.07m322.10m245.0078.868.7775.5111.430.01860.01860.12920.16760.55762.384.2282,143.597.8012.8111.2720.9234.7333.5813.9914.602.27--0.27020.003.29-1.076.34-4.80-9.50--
Utah Medical Products, Inc.65.20m21.88m325.89m169.0015.461.8911.775.004.334.3312.9235.450.35761.9912.81275,609.5012.0012.6912.4313.1958.9961.5733.5630.5123.68--0.0037.05-3.933.640.98341.659.711.86
Electromed Inc79.87m9.05m326.93m174.0038.305.6631.934.090.72560.72566.404.911.233.372.42327,931.0013.918.6416.2210.0976.6276.2611.348.065.06--0.000.0013.8311.8262.6721.06-22.23--
Trubridge Inc471.08m-73.17m329.91m3.22k--1.30--0.7003-3.68-3.6823.6412.120.7947196.765.88104,553.30-12.661.25-14.341.4148.7050.40-15.931.561.760.61150.498545.063.913.89-387.73--88.71--
Hamilton Thorne Ltd101.58m-2.37m340.09m----3.9052.673.35-0.0158-0.01580.67170.57450.72922.648.29---1.701.50-2.061.7850.6850.84-2.342.181.070.89780.2919--15.5518.14-131.77--26.56--
Inogen Inc464.03m-73.74m342.95m834.00--1.33--0.7391-2.25-2.2514.097.781.027.818.03397,506.00-16.21-8.23-20.38-9.5344.2244.54-15.89-10.312.34--0.00---16.32-2.49-22.30--26.34--
Anika Therapeutics Inc229.79m-136.50m349.31m357.00--1.39--1.52-6.64-6.6411.1412.240.58681.475.21459,854.30-34.86-5.41-38.55-5.8762.7060.70-59.40-12.603.78--0.00--6.679.56-456.34--3.11--
Atlantic International Corp287.30m-87.18m350.95m7.00--9.58--1.22-8.72-8.7214.590.52222.91--7.0329,322,780.00-88.44-71.97-174.30-106.0910.7061.01-30.35-1,471.82---1.330.7735---100.00---37.43------
Zynex Inc271.07m6.75m362.39m1.10k54.907.3527.691.340.14810.14815.911.111.402.577.05176,059.103.4814.584.0617.5280.2079.622.4910.443.154.150.6246--16.5442.01-42.910.37412.19--
Pulmonx Corp111.00m-79.93m371.42m279.00--2.83--3.35-1.47-1.472.042.380.451.247.29284,236.60-32.41-26.27-36.42-28.9774.1671.95-72.01-93.766.77--0.2839--27.9827.98-3.26--20.62--
Neuropace Inc100.53m-41.85m382.27m171.00--26.97--3.80-1.09-1.092.610.33920.73051.746.49419,994.20-30.41---34.66--74.15---41.63--5.47-4.370.8565--43.72--30.00------
AngioDynamics, Inc.409.73m-340.17m397.56m748.00--1.46--0.9703-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
Data as of Nov 13 2024. Currency figures normalised to Hamilton Thorne Ltd's reporting currency: Canadian Dollar CAD

Institutional shareholders

30.08%Per cent of shares held by top holders
HolderShares% Held
AWM Investment Co., Inc.as of 10 Oct 202414.80m9.61%
Claret Asset Management Corp.as of 30 Nov 202314.76m9.59%
CI Investments, Inc.as of 31 Mar 20247.42m4.82%
Swedbank Robur Fonder ABas of 30 Sep 20242.50m1.62%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 20231.67m1.09%
Maxam Capital Management Ltd.as of 30 Jun 20241.59m1.03%
Didner & Gerge Fonder ABas of 30 Jun 20241.42m0.92%
NCM Asset Management Ltd.as of 31 Mar 20241.17m0.76%
1832 Asset Management LPas of 30 Jun 2024811.29k0.53%
Connor, Clark & Lunn Investment Management Ltd.as of 30 Jun 2024152.04k0.10%
More ▼
Data from 31 Mar 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.